{
    "title": "Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml",
    "link": "https://www.medscape.com/cx/rssfeeds/2700.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-09-25T16:29:33.644460",
    "items": [
        {
            "title": "Federal Bill Would Free Up Visas to Ease Physician Shortage",
            "link": "https://www.medscape.com/viewarticle/bipartisan-bill-would-free-visas-ease-physician-shortage-2025a1000pqi?src=rss",
            "description": "Federal lawmakers have revived a bill to allocate unused visas to as many as 15,000 foreign-born doctors, even as recent White House immigration decis...",
            "pubDate": "2025-09-25T20:49:53",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Stop Young Physician Suicide",
            "link": "https://www.medscape.com/viewarticle/michigan-psychiatry-professors-mission-stop-young-physician-2025a1000pq9?src=rss",
            "description": "A friendâ€™s death and his own struggles in residency set Srijan Sen on path toward prevention. Medscape Medical News",
            "pubDate": "2025-09-25T17:43:37",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Is Lower-Dose Ribociclib Equally Effective in Breast Cancer?",
            "link": "https://www.medscape.com/viewarticle/lower-dose-ribociclib-equally-effective-breast-cancer-2025a1000pnx?src=rss",
            "description": "Researchers compared ribociclib 400 mg with ribociclib 600 mg plus a nonsteroidal aromatase inhibitor in patients with hormone receptor-positive/ERBB2...",
            "pubDate": "2025-09-25T16:05:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Ribociclib Shows Lasting Benefit in Early Breast Cancer",
            "link": "https://www.medscape.com/viewarticle/ribociclib-shows-lasting-benefit-early-breast-cancer-2025a1000pol?src=rss",
            "description": "Researchers examined invasive disease-free survival rates at 4 years in a randomized phase 3 trial of adjuvant treatment for women and men with HR+/ER...",
            "pubDate": "2025-09-25T16:05:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png"
        },
        {
            "title": "Oral IL-23 Inhibitor Bests JAK Inhibitor in Psoriasis Trials",
            "link": "https://www.medscape.com/viewarticle/novel-oral-il-23-inhibitor-superior-jak-inhibitor-psoriasis-2025a1000ppj?src=rss",
            "description": "A nonbiologic oral IL-23 inhibitor is more effective and safer than an approved oral JAK inhibitor for moderate-to-severe psoriasis in a head-to-head ...",
            "pubDate": "2025-09-25T14:35:10",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png"
        }
    ]
}